Spironolactone Tablets, Usp 50 mg Bottle Label (Image 01)
Spironolactone Tablet, Film Coated
Product Images NDC 0378-2146
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 0378-2146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
Image 03
This appears to be a table or chart with information on subgroups for a study or trial related to heart failure. The subgroups may be divided by age, sex, race, left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) classification, presence of diabetes, serum creatinine and clearance, potassium levels, use of digoxin or beta blockers, and whether the condition is non-ischemic or ischemic. There are also columns for the number of patients at different heart rates and whether they were given Spironolactone or Placebo.*
Image 04
Image 05
Image 06
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
